首页> 外文期刊>Autoimmunity reviews >Wegener's Granulomatosis vasculitis and granuloma.
【24h】

Wegener's Granulomatosis vasculitis and granuloma.

机译:韦格纳肉芽肿性血管炎和肉芽肿。

获取原文
获取原文并翻译 | 示例
           

摘要

Wegener's Granulomatosis (WG) is an autoimmune disease with manifestations in different organ systems. The hallmark of WG is a necrotizing granulomatous inflammation of the upper and/or lower respiratory tract and systemic small vessel vasculitis which can involve multiple organ systems. The treatment of WG has evolved over the last decades. Steroid, cytotoxic and biologic therapies have been used leading to great improvements in outcome. However, still mortality is high and relapses are a major cause of mortality and morbidity. Despite intensified maintenance regimens and new possibilities of biologic therapies in WG the relapse rate is high. Even patients treated with high dose cytotoxic therapies in autologous stem cell treatment protocols have shown relapses in the course of disease. Increasing knowledge of the pathophysiology of granuloma in WG and new biologic therapies might be of great importance for future treatment of WG.
机译:韦格纳肉芽肿病(WG)是一种自身免疫性疾病,在不同器官系统中都有表现。 WG的标志是上呼吸道和/或下呼吸道坏死性肉芽肿性炎症和全身性小血管血管炎,可能累及多个器官系统。在过去的几十年中,WG的治疗方法得到了发展。类固醇,细胞毒性和生物疗法已被使用,从而导致预后大大改善。但是,死亡率仍然很高,复发是死亡率和发病率的主要原因。尽管加强了维护方案并在WG中采用了生物疗法,但复发率仍然很高。甚至在自体干细胞治疗方案中接受高剂量细胞毒性疗法治疗的患者也显示出疾病过程中的复发。对WG中肉芽肿的病理生理学的了解和新的生物疗法可能对WG的未来治疗具有重要意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号